About
InBody is a global leader in body composition analysis technology, founded in 1996 in South Korea by Dr. Kichul Cha. The company developed innovative devices that utilize direct segmental multi-frequency bioelectrical impedance analysis (DSM-BIA) and an eight-point tactile electrode system. This technology provides precise and reliable body composition data, making it a trusted choice for medical, fitness, and wellness professionals worldwide. InBody offers a variety of body composition analyzers, including the InBody 570 and InBody 770, which are designed for detailed segmental fat and muscle analysis. The product lineup also features portable analyzers like the InBody 270, wearable devices such as the InBody BAND, and cloud-based software for data management. InBody serves a diverse customer base, including medical institutions, fitness centers, research organizations, and individual consumers, all focused on promoting healthier lifestyles through comprehensive body composition insights. The company is committed to continuous innovation and has received multiple awards for its design and technology excellence.
Keywords
Company Information
-
Employees 270
-
Founded 1996
-
Annual Revenue $155233000
Location
Seoul, South Korea, 135-010
